Oxford Biomedica signs deal to acquire of ABL Europe for €15 million
OXFORD, UK: Oxford Biomedica plc has entered into a sale and purchase agreement with TSGH SAS, a subsidiary of Institut Mérieux SA, for the acquisition...
Oxford Biomedica Plc (LSE:OXB)
Oxford Biomedica Plc (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford Biomedica...